1|Page
NURS 660 EXAM 2 QUESTIONS WITH CORRECT
VERIFIED SOLUTIONS 100% GUARANTEED PASS
(LATEST UPDATE) .
1. A patient with rapid cycling bipolar disorder is being started on medication
therapy. Which medication combination should NOT be given together?
A. Lithium and lurasidone
B. Lamotrigine and quetiapine
C. Carbamazepine and lurasidone
D. Valproate and quetiapine
CORRECT ANSWER: C. Carbamazepine and lurasidone
Rationale: Carbamazepine is a potent CYP3A4 inducer that significantly decreases
lurasidone levels, making this combination ineffective and potentially dangerous.
2. A patient is currently taking a monoamine oxidase inhibitor (MAOI) and requires
an additional medication. Which medication is safe to administer with an MAOI?
A. Meperidine
, 2|Page
B. Lithium
C. Tramadol
D. Dextromethorphan
CORRECT ANSWER: B. Lithium
Rationale: Lithium is safe to use with MAOIs as it does not interact with
monoamine oxidase inhibition. Other medications listed have potentially fatal
interactions with MAOIs.
3. A patient presents with depressive symptoms, and the provider needs to
determine if this is unipolar or bipolar depression. What two factors are most
useful for making this determination?
A. Age of onset and gender
B. Family history and input from someone close to the patient
C. Duration of symptoms and previous treatment response
D. Sleep patterns and appetite changes
CORRECT ANSWER: B. Family history and input from someone close to the
patient
Rationale: Family history of bipolar disorder and collateral information from
family/friends about possible manic or hypomanic episodes are the most useful
factors in distinguishing bipolar from unipolar depression.
NURS 660 EXAM 2 QUESTIONS WITH CORRECT
VERIFIED SOLUTIONS 100% GUARANTEED PASS
(LATEST UPDATE) .
1. A patient with rapid cycling bipolar disorder is being started on medication
therapy. Which medication combination should NOT be given together?
A. Lithium and lurasidone
B. Lamotrigine and quetiapine
C. Carbamazepine and lurasidone
D. Valproate and quetiapine
CORRECT ANSWER: C. Carbamazepine and lurasidone
Rationale: Carbamazepine is a potent CYP3A4 inducer that significantly decreases
lurasidone levels, making this combination ineffective and potentially dangerous.
2. A patient is currently taking a monoamine oxidase inhibitor (MAOI) and requires
an additional medication. Which medication is safe to administer with an MAOI?
A. Meperidine
, 2|Page
B. Lithium
C. Tramadol
D. Dextromethorphan
CORRECT ANSWER: B. Lithium
Rationale: Lithium is safe to use with MAOIs as it does not interact with
monoamine oxidase inhibition. Other medications listed have potentially fatal
interactions with MAOIs.
3. A patient presents with depressive symptoms, and the provider needs to
determine if this is unipolar or bipolar depression. What two factors are most
useful for making this determination?
A. Age of onset and gender
B. Family history and input from someone close to the patient
C. Duration of symptoms and previous treatment response
D. Sleep patterns and appetite changes
CORRECT ANSWER: B. Family history and input from someone close to the
patient
Rationale: Family history of bipolar disorder and collateral information from
family/friends about possible manic or hypomanic episodes are the most useful
factors in distinguishing bipolar from unipolar depression.
